Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
NCT05153304
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
funding
Conditions
Cancer of Gastrointestinal Tract
Interventions
BIOLOGICAL:
personalized vaccine
DRUG:
Nivolumab
Sponsor
University of California, San Diego